Breast

Article	Citations
Current and future burden of breast cancer: Global statistics for 2020 and 2040	679
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic	160
The requirements of a specialist breast centre	109
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer	87
Global guidelines for breast cancer screening: A systematic review	77
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial	64
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST)	58
Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review	55
Epidemiology of male breast cancer	54
Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis	48
Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis	46
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis	46
Dissecting the biological heterogeneity of HER2-positive breast cancer	45
Global challenges in breast cancer detection and treatment	45
Effects of the COVID-19 pandemic on breast cancer screening in Taiwan	41
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance	38
The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis	36
Occult breast cancer: Where are we at?	35
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy	34
A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction	34
Breast cancer surgery with augmented reality	33
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data fr	33
Tailored axillary surgery in patients with clinically node-positive breast cancer: Pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)	31
Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening	30
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer	30

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis	30
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer	30
The emerging role of BET inhibitors in breast cancer	29
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis	29
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis	29
Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice	27
Targeting ADCC: A different approach to HER2 breast cancer in the immunotherapy era	26
Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis	26
Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort	26
Comparison of complications according to incision types in nipple-sparing mastectomy and immediate reconstruction	26
De-escalating axillary surgery in early-stage breast cancer	25
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study	25
Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D	25
The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy	25
Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability	24
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer	24
A video-game based cognitive training for breast cancer survivors with cognitive impairment: A prospective randomized pilot trial	24
A multidisciplinary view of mastectomy and breast reconstruction: Understanding the challenges	24
Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,5	23
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis	23
Effect of pathologic stages on postmastectomy radiation therapy in breast cancer receiving neoadjuvant chemotherapy and total mastectomy: A Cancer Database Analysis	22
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL	22
Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: A national matched cohort study	22
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective	22
Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis	22
“The emerging role of capivasertib in breast cancer”	21
Psychoeducation for breast cancer: A systematic review and meta-analysis	21
Breast-related and body-related quality of life following autologous breast reconstruction is superior to implant-based breast reconstruction - A long-term follow-up study	21
A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis	20
Potential immune response to breast implants after immunization with COVID-19 vaccines	20
Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer	20
Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy	20
Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder	20
Hypofractionated versus conventional fractionated radiotherapy for breast cancer in patients with reconstructed breast: Toxicity analysis	19
Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto	19
Antibody drug conjugates targeting HER2: Clinical development in metastatic breast cancer	19
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study	19
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled B	19
Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics	18
Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis	18
Tired of feeling tired – The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivors	18
Machine learning to predict individual patient-reported outcomes at 2-year follow-up for women undergoing cancer-related mastectomy and breast reconstruction (INSPiRED-001)	18
Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study	18
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial	17
A prospective cohort study of the safety of breast cancer surgery during COVID-19 pandemic in the West of Scotland	17
Preoperative non-palpable breast lesion localization, innovative techniques and clinical outcomes in surgical practice: A systematic review and meta-analysis	17
Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer	17
Calorie restriction and synbiotics effect on quality of life and edema reduction in breast cancer-related lymphedema, a clinical trial	17
Impact of body mass index on overall survival in patients with metastatic breast cancer	17
Interstitial lung disease in patients treated with Cyclin-Dependent Kinase 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials	17

Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials	17
Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer	17
The role of CDK4/6 inhibitors in early breast cancer	16
Pathology after neoadjuvant treatment – How to assess residual disease	16
Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India	16
Palbociclib dose reductions and the effect on clinical outcomes in patients with advanced breast cancer	16
Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations	16
Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies	16
Pathways to breast cancer screening artificial intelligence algorithm validation	16
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer	16
Immediate Breast Reconstruction after mastectomy with polyurethane implants versus textured implants: A retrospective study with focus on capsular contracture	16
Adverse health effects after breast cancer up to 14 years after diagnosis	16
Positive effects of the enhanced recovery after surgery (ERAS) protocol in DIEP flap breast reconstruction	16
Population-based mammography screening attendance in Sweden 2017–2018: A cross-sectional register study to assess the impact of sociodemographic factors	16
Interassay and interobserver comparability study of four programmed death-ligand 1 (PD-L1) immunohistochemistry assays in triple-negative breast cancer	16
Breast cancer screening using synthesized two-dimensional mammography: A systematic review and meta-analysis	15
Axillary surgery in node-positive breast cancer	15
Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis	14
Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden	14
Neoadjuvant chemotherapy and HER2 dual blockade including biosimilar trastuzumab (SB3) for HER2-positive early breast cancer: Population based real world data from the Danish Breast Cancer Group (DBCG	14
Is breast conservation superior to mastectomy in early stage triple negative breast cancer?	14
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study	14
Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients	14
Compliance with multidisciplinary team recommendations and disease outcomes in early breast cancer patients: An analysis of 4501 consecutive patients	14
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors	14
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study	14
Predictive and prognostic values of tumor infiltrating lymphocytes in breast cancers treated with neoadjuvant chemotherapy: A meta-analysis	14
“This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients”	14
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective	14
Prevalence of symptomatic dry eye in breast cancer patients undergoing systemic adjuvant treatment: A cross-sectional study	14
Phyllodes tumors of the breast: Adjuvant radiation therapy revisited	14
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up	14
On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19	13
Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkers	13
Clinical characteristics and survival outcome of patients with estrogen receptor low positive breast cancer	13
NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients	13
Moment of truth-adding carboplatin to neoadjuvant/adjuvant chemotherapy in triple negative breast cancer improves overall survival: An individual participant data and trial-level Meta-analysis	13
Radiological audit of interval breast cancers: Estimation of tumour growth rates	13
Omission of axillary sentinel lymph node biopsy in early invasive breast cancer	13
Polygenic risk scores and breast cancer risk prediction	13
Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial	13
Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis	13
Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials	13
Evaluation of the 8th edition of the American joint committee on cancer’s pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastect	13
Mammographic density and prognosis in primary breast cancer patients	13
Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastati	13
Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study	13
The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review	13
Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation study	13
Low neighborhood socioeconomic status is associated with higher mortality and increased surgery utilization among metastatic breast cancer patients	13
Effects of physical exercise on cognitive function of breast cancer survivors receiving chemotherapy: A systematic review of randomized controlled trials	12
Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates	12
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?	12
Symptoms in long-term breast cancer survivors: A cross-sectional study in primary care	12
CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancer	12
Quality and reporting of clinical guidelines for breast cancer treatment: A systematic review	12
Mammographic sensitivity as a function of tumor size: A novel estimation based on population-based screening data	12
Immediate direct-to-implant breast reconstruction with acellular dermal matrix: Evaluation of complications and safety	12
A multidisciplinary approach to optimizing care of patients treated with alpelisib	12
Quality indicators for breast cancer care: A systematic review	12
Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia	12
Ribociclib plus letrozole in subgroups of special clinical interest with hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: Subgroup analysis of the p	12
Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer	12
Impacts of clinicopathological factors on efficacy of trastuzumab deruxtecan in patients with HER2-positive metastatic breast cancer	11
Which clinical, radiological, histological, and molecular parameters are associated with the absence of enhancement of known breast cancers with Contrast Enhanced Digital Mammography (CEDM)?	11
Trastuzumab deruxtecan versus trastuzumab emtansine for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A cost-effectiveness analysis	11
Pregnancy associated breast cancer (PABC): Report from a gestational cancer registry from a tertiary cancer care centre, India	11
Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer	11
Risk communication in a patient decision aid for radiotherapy in breast cancer: How to deal with uncertainty?	11
Clinicopathological and genomic features of breast mucinous carcinoma	11
Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost	11
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis	11
Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China	11
Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab	11
Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data	11
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations	11
Retrospective study of malignant phyllodes tumors of the breast: Younger age, prior fibroadenoma surgery, malignant heterologous elements and surgical margins may predict recurrence	11
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study	11
Individualized-thresholding Shear Wave Elastography combined with clinical factors improves specificity in discriminating breast masses	11
Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients	11

Decisional conflict in breast cancer patients considering immediate breast reconstruction	11
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world mul	11
The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA	10
Differences in breast cancer risk after benign breast disease by type of screening diagnosis	10
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective	10
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A pro	10
Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer	10
Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients	10
The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype	10
A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting	10
How I treat HER2-low advanced breast cancer	10
A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer	10
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personali	10
Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial	10
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study	10
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program	10
Epidemiological features of primary breast lymphoma patients and development of a nomogram to predict survival	10
Treatment of adenoid cystic carcinoma of the breast: Is postoperative radiation getting its due credit?	9
Dual HER2 blockade in the first-line treatment of metastatic breast cancer - A retrospective population-based observational study in Danish patients	9
Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study	9
Effects of weight reduction on the breast cancer-related lymphedema: A systematic review and meta-analysis	9
Rates of margin positive resection with breast conservation for invasive breast cancer using the NCDB	9
Residual breast tissue after robot-assisted nipple sparing mastectomy	9
Real life efficacy of palbociclib and endocrine therapy in HR positive, HER2 negative advanced breast cancer	9
The effect of family history on screening procedures and prognosis in breast cancer patients - Results of a large population-based case-control study	9
Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)	9
Giving meaning to patient reported outcomes in breast reconstruction after mastectomy – A systematic review of available scores and suggestions for further research	9
Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis	9
Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study	9
Locally advanced breast cancer	9
Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study	9
Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer	9
Anthracyclines in the treatment of early breast cancer friend or foe?	9
First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study	9
Breast magnetic resonance imaging as a problem solving tool in women recalled at biennial screening mammography: A population-based study in the Netherlands	9
Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review	8
A pilot study evaluating the effect of early physical therapy on pain and disabilities after breast cancer surgery: Prospective randomized control trail	8
Presentation and survival by hormonal receptor status in metaplastic breast cancer: A propensity score-matched analysis	8
Association of molecular subtype concordance and survival outcome in synchronous and metachronous bilateral breast cancer	8
Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study	8
Are English-language online patient education materials related to breast cancer risk assessment understandable, readable, and actionable?	8
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study	8
Is the skin microbiota a modifiable risk factor for breast disease?: A systematic review	8
Breast cancer survival in Brazil: How much health care access impact on cancer outcomes?	8
Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer：A multicenter study	8
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe	8
Development and external validation of a nomogram to predict four or more positive nodes in breast cancer patients with one to three positive sentinel lymph nodes	8
Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives	8
Acinic cell carcinoma of the breast: A comprehensive review	8
Eligibility of real-world patients with metastatic breast cancer for clinical trials	8
Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancer	8
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer	8
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making	8
Ovarian reserve of women with and without BRCA pathogenic variants: A systematic review and meta-analysis	8
Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials	8
Health state utilities for metastatic breast cancer in Taiwan	8
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy	8
Development of novel agents for the treatment of early estrogen receptor positive breast cancer	8
Chemotherapy and 21-gene recurrence score testing for older breast cancer patients: A competing-risks analysis	8
Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer	8
Evolution of physical activity and body weight changes in breast cancer survivors five years after diagnosis – VICAN 2 & 5 French national surveys	8
Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy	8
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study	8
HER2 positivity is not associated with adverse prognosis in high-risk estrogen receptor-positive early breast cancer patients treated with chemotherapy and trastuzumab	8
Hypofractionation with simultaneous integrated boost after breast-conserving surgery: Long term results of two phase-II trials	8
Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer	8
Prevalence, trend and disparities of palliative care utilization among hospitalized metastatic breast cancer patients who received critical care therapies	8
The impact of standardized structured reporting of pathology reports for breast cancer care	8
Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China	8
Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study	7
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib	7
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer	7
Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS study	7
A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments	7
Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant	7
Fertility in Breast Cancer Survivors in the Middle East: A Retrospective Study	7
BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implications	7
Effects of supervised exercise during adjuvant endocrine therapy in overweight or obese patients with breast cancer: The I-MOVE study	7
Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer	7
Trastuzumab emtansine for HER2-positive metastatic breast cancer: Outcomes from a whole-of-population Australian cohort	7
Evaluation of physician performance using a concurrent-read artificial intelligence system to support breast ultrasound interpretation	7
Tailored axillary surgery – A novel concept for clinically node positive breast cancer	7
Real de-escalation or escalation in disguise?	7
Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal	7
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin	7
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain	7
A novel algorithm to reduce VTE in peri-operative patients on tamoxifen	7
Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy	7
Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer	7
Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update	7
Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis	7
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases	7
Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade	7
Older women’s experience with breast cancer treatment: A systematic review of qualitative literature	7
Barrier films for the prevention of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomised controlled trials	7